Differential T4 Degradation Pathways in Young Patients with Preterminal and Terminal Renal Failure

Abstract

Introduction: The aim of this study is to analyze thyroid hormone parameters in large homogenous patient cohorts with preterminal (stage 4) and terminal (stage 5) renal failure in an area of low iodine intake.

Patients and Methods: Thyroid parameters were measured in healthy controls (n=48), patients with preterminal renal failure (n=48) and patients with terminal renal failure undergoing hemodialysis (n=288). All patients were assessed by measurement of TSH, T4, T3, fT4, rT3, Tg and TPO-antibodies.

Results: There was a significant decrease of T4 and fT4 from healthy controls to patients with preterminal renal failure and to patients with terminal renal failure. T3 showed a decrease from healthy controls to patients with preterminal renal failure and to patients with terminal renal failure (1.54±0.06 μg/l vs. 1.05±0.05 μg/l vs. 1.09±0.23 μg/l, p<0.001 vs. controls). rT3 was significantly decreased in patients with terminal renal failure (0.24±0.01 μg/l vs. 0.25±0.02 μg/l vs. 0.16±0.01 μg/l, p<0.001). The rT3/T3 ratio was significantly elevated in patients with preterminal renal failure (p<0.01). TSH concentrations were in the normal range in all groups.

Conclusion: Our data suggest different T4 degradation pathways in patients with preterminal and terminal renal failure.

Key words

dialysis - non-thyroidal illness - renal failure - rT3 - TSH (Thyroid-Stimulating Hormone)

References

• 1 Docter R, Krenning EP, de Jong M, Hennemann G. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism.  Clin Endocrinol (Oxf). 1993;  39 499-518
• 2 Lo JC, Chertow GM, Go AS, Hsu CY. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease.  Kidney Int. 2005;  67 1047-1052
• 3 De Marchi S, Cecchin E, Villalta D, Tesio F. Serum reverse T3 assay for predicting glucose intolerance in uremic patients on dialysis therapy.  Clin Nephrol. 1987;  27 189-198
• 4 Lim VS. Thyroid function in patients with chronic renal failure.  Am J Kidney Dis. 2001;  38 ((Suppl 1)) S80-S84
• 5 Verger MF, Verger C, Hatt-Magnien D, Perrone F. Relationship between thyroid hormones and nutrition in chronic renal failure.  Nephron. 1987;  45 211-215
• 6 Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P. Low triiodothyronine and survival in end-stage renal disease.  Kidney Int. 2006;  70 523-528
• 7 Kaptein EM, Quion-Verde H, Chooljian CJ, Tang WW, Friedman PE, Rodriquez HJ, Massry SG. The thyroid in end-stage renal disease.  Medicine. 1988;  67 187-197
• 8 Goffin E, Oliveria DB, Raggatt P, Evans DB. Assessment of the thyroid function of patients undergoing regular haemodialysis.  Nephron. 1993;  65 568-572
• 9 Nishikawa M, Ogawa Y, Yoshikawa N, Yoshimura M, Toyoda N, Shouzu A, Inada M. Plasma free thyroxine (FT4) concentrations during hemodialysis in patients with chronic renal failure: effects of plasma non-esterified fatty acids on FT4 measurement.  Endocr J. 1996;  43 487-493
• 10 National Kidney Foundation . Dialysis Outcomes Quality Initiative.  Am J Kidney Dis. 2002;  39 ((Suppl)) S1-S266
• 11 Amado JA, Suarez M, de Francisco AM. Thyroglobulin and thyroid function in patients on regular hemodialysis.  Nephron. 1986;  43 160
• 12 Iitaka M, Kawasaki S, Sakurai S, Hara Y, Kuriyama R, Yamanaka K, Kitahama S, Miura S, Kawakami Y, Katayama S. Serum substances that interfere with thyroid hormone assays in patients with chronic renal failure.  Clin Endocrinol. 1998;  48 739-746
• 13 Yonemura K, Nakajima T, Suzuki T, Ando S, Genma R, Nakamura H, Hishida A. Low free thyroxine concentrations and deficient nocturnal surge of thyroid-stimulating hormone in haemodialysed patients compared with undialysed patients.  Nephrol Dial Transplant. 2000;  15 668-672
• 14 Faber J, Heaf J, Kirkegaard C, Lumholtz IB, Siersbaek-Nielsen K, Kolendorf K, Friis T. Simultaneous turnover studies of thyroxine, 3,5,3′ and 3,3′,5′-triiodothyronine, 3,5-, 3,3′-, and 3′,5′-diiodothyronine, and 3′-monoiodothyronine in chronic renal failure.  J Clin Endocrinol Metab. 1983;  56 211-217
• 15 Lim VS, Fang VS, Katz AI, Refetoff S. Thyroid dysfunction in chronic renal failure. A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine.  J Clin Invest. 1977;  60 522-534
• 16 Kaptein EM, Kaptein JS, Chang EI, Egodage PM, Nicoloff JT, Massry SG. Thyroxine transfer and distribution in critical nonthyroidal illnesses, chronic renal failure, and chronic ethanol abuse.  J Clin Endocrinol Metab. 1987;  65 606-616
• 17 Spector DA, Davis PJ, Helderman JH, Bell B, Utiger RD. Thyroid function and metabolic state in chronic renal failure.  Ann Intern Med. 1976;  85 724-730
• 18 Zoccali C, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F. Low triiodothyronine: A new facet of inflammation in end-stage renal disease.  J Am Soc Nephrol. 2005;  16 2789-2795
• 19 Kosowicz J, Malczewska B, Czekalski S. Serum reverse triiodothyronine (3,3′,5′-l-triiodothyronine) in chronic renal failure.  Nephron. 1980;  26 85-89
• 20 Thysen B, Gatz M, Freeman R, Alpert BE, Charytan C. Serum thyroid hormone levels in patients on continuous ambulatory peritoneal dialysis and regular hemodialysis.  Nephron. 1983;  33 49-52
• 21 Kaptein EM, Feinstein EI, Nicoloff JT, Massry SG. Serum reverse triiodothyronine and thyroxine kinetics in patients with chronic renal failure.  J Clin Endocrinol Metab. 1983;  57 181-189
• 22 van Leusen R, Meinders AE. Cyclical changes in serum thyroid hormone concentrations related to hemodialysis: movement of hormone into and out of the extravascular space as a possible mechanism.  Clin Nephrol. 1982;  18 193-199
• 23 Köhrle J, Jakob F, Contempré B, Dumont JE. Selenium, the thyroid, and the endocrine system.  Endocrine Reviews. 2005;  26 944-984
• 24 Yilmaz MI, Saglam M, Caglar K, Cakir E, Sonmez A, Ozgurtas T, Aydin A, Eyileten T, Ozcan O, Acikel C, Tasar M, Genctoy G, Erbil K, Vural A, Zoccali C. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine.  Am J Kidney Dis. 2006;  47 42-50
• 25 Peters H, Stephan-Sump F, Rauhut E, Brätter E, Distler A. Selenium substitution improves thyroid de-iodination in patients on chronic hemodialysis.  Kidney Blood Press Res. 1998;  21 A
• 26 Volzke H, Alte D, Kohlmann T, Ludemann J, Nauck M, John U, Meng W. Reference intervals of serum thyroid function tests in a previously iodine-deficient area.  Thyroid. 2005;  15 279-285
• 27 Custro N, Scafidi V, Gallo S, Notarbartolo A. Deficient pulsatile thyrotropin secretion in the low-thyroid-hormone state of severe non-thyroidal illness.  Eur J Endocrinol. 1994;  130 132-136

Correspondence